Natural Compounds for Counteracting Nonalcoholic Fatty Liver Disease (NAFLD): Advantages and Limitations of the Suggested Candidates
出版年份 2022 全文链接
标题
Natural Compounds for Counteracting Nonalcoholic Fatty Liver Disease (NAFLD): Advantages and Limitations of the Suggested Candidates
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 5, Pages 2764
出版商
MDPI AG
发表日期
2022-03-03
DOI
10.3390/ijms23052764
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Verbascoside inhibits the epithelial‐mesenchymal transition of prostate cancer cells through high‐mobility group box 1/receptor for advanced glycation end‐products/ TGF ‐β pathway
- (2021) Chun‐Hsien Wu et al. ENVIRONMENTAL TOXICOLOGY
- Caffeic acid prevents non-alcoholic fatty liver disease induced by a high-fat diet through gut microbiota modulation in mice
- (2021) Hong-Na Mu et al. FOOD RESEARCH INTERNATIONAL
- Effects of supplementation with main coffee components including caffeine and/or chlorogenic acid on hepatic, metabolic, and inflammatory indices in patients with non-alcoholic fatty liver disease and type 2 diabetes: a randomized, double-blind, placebo-controlled, clinical trial
- (2021) Asieh Mansour et al. Nutrition Journal
- The Occurrence and Biological Activity of Tormentic Acid—A Review
- (2021) Marta Olech et al. MOLECULES
- Tormentic acid inhibits hepatic stellate cells activation via blocking PI3K /Akt/ mTOR and NF‐κB signalling pathways
- (2020) Xing Lin et al. CELL BIOCHEMISTRY AND FUNCTION
- Multiple Parallel Hits Hypothesis in NAFLD – Revisited After a Decade
- (2020) Herbert Tilg et al. HEPATOLOGY
- Fish oil and chicoric acid combination protects better against palmitate-induced lipid accumulation via regulating AMPK-mediated SREBP-1/FAS and PPARα/UCP2 pathways
- (2020) Mohammad Mohammadi et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: A meta-analysis of 11 epidemiological studies
- (2020) Umar Hayat et al. Annals of Hepatology
- Effects of a Low Dose of Caffeine Alone or as Part of a Green Coffee Extract, in a Rat Dietary Model of Lean Non-Alcoholic Fatty Liver Disease without Inflammation
- (2020) Ana Magdalena Velázquez et al. Nutrients
- Neuroprotective Potential of Verbascoside Isolated from Acanthus mollis L. Leaves through Its Enzymatic Inhibition and Free Radical Scavenging Ability
- (2020) Carmen Burgos et al. Antioxidants
- Verbascoside Protects Pancreatic β-Cells against ER-Stress
- (2020) Alessandra Galli et al. Biomedicines
- Differential effects of a combination of Hibiscus sabdariffa and Lippia citriodora polyphenols in overweight/obese subjects: A randomized controlled trial
- (2019) María Herranz-López et al. Scientific Reports
- Herbal drug discovery for the treatment of nonalcoholic fatty liver disease
- (2019) Tingting Yan et al. Acta Pharmaceutica Sinica B
- Non-Alcoholic Fatty Liver Disease in Children and Adolescents: Lifestyle Change - a Systematic Review and Meta-Analysis
- (2018) Melina Utz-Melere et al. Annals of Hepatology
- Caffeic acid ameliorates hepatic steatosis and decreased endoplasmic reticulum stress in high-fat diet-induced obese mice by regulating autophagy
- (2018) Hong Min Kim et al. NUTRITION
- Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review
- (2018) Mohammad Bagherniya et al. PHARMACOLOGICAL RESEARCH
- Caffeine-inducible gene switches controlling experimental diabetes
- (2018) Daniel Bojar et al. Nature Communications
- Coffee Intake and Liver Steatosis: A Population Study in a Mediterranean Area
- (2018) Nicola Veronese et al. Nutrients
- Nonalcoholic Liver Disease in Children and Adolescents
- (2018) Sara Kathryn Smith et al. Clinics in Liver Disease
- Cichoric Acid Prevents Free-Fatty-Acid-Induced Lipid Metabolism Disorders via Regulating Bmal1 in HepG2 Cells
- (2018) Rui Guo et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Selective Synthesis of 3-O-Palmitoyl-Silybin, a New-to-Nature Flavonolignan with Increased Protective Action against Oxidative Damages in Lipophilic Media
- (2018) Samantha Drouet et al. MOLECULES
- Nonalcoholic Fatty Liver Disease
- (2018) Irene Pierantonelli et al. TRANSPLANTATION
- Caffeine-stimulated muscle IL-6 mediates alleviation of non-alcoholic fatty liver disease
- (2018) Chongye Fang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Polyphenolic extract attenuates fatty acid-induced steatosis and oxidative stress in hepatic and endothelial cells
- (2017) Laura Vergani et al. EUROPEAN JOURNAL OF NUTRITION
- Caffeine affects HFD-induced hepatic steatosis by multifactorial intervention
- (2017) MG Helal et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms
- (2017) Shira Zelber-Sagi et al. LIVER INTERNATIONAL
- PTP1B inhibitory and cytotoxic activities of triterpenoids from the aerial parts of Agrimonia pilosa
- (2017) Bing Tian Zhao et al. MEDICINAL CHEMISTRY RESEARCH
- Daily Coffee Intake Inhibits Pancreatic Beta Cell Damage and Nonalcoholic Steatohepatitis in a Mouse Model of Spontaneous Metabolic Syndrome, Tsumura-Suzuki Obese Diabetic Mice
- (2017) Syunsuke Watanabe et al. Metabolic Syndrome and Related Disorders
- Chicoric acid attenuate a nonalcoholic steatohepatitis by inhibiting key regulators of lipid metabolism, fibrosis, oxidation, and inflammation in mice with methionine and choline deficiency
- (2017) Myungsuk Kim et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Comparison of dietary polyphenols for protection against molecular mechanisms underlying nonalcoholic fatty liver disease in a cell model of steatosis
- (2017) Hossein Rafiei et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Protective Effects of Tormentic Acid, a Major Component of Suspension Cultures of Eriobotrya japonica Cells, on Acetaminophen-Induced Hepatotoxicity in Mice
- (2017) Wen-Ping Jiang et al. MOLECULES
- Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes
- (2017) Robin Poole et al. BMJ-British Medical Journal
- Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes
- (2017) Robin Poole et al. BMJ-British Medical Journal
- Lifestyle Interventions Including Nutrition, Exercise, and Supplements for Nonalcoholic Fatty Liver Disease in Children
- (2016) Jonathan A. Africa et al. DIGESTIVE DISEASES AND SCIENCES
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Tormentic acid inhibits H2O2-induced oxidative stress and inflammation in rat vascular smooth muscle cells via inhibition of the NF-κB signaling pathway
- (2016) Yu-Lun Wang et al. Molecular Medicine Reports
- EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease
- (2016) Obesity Facts
- Coffee, caffeine and non-alcoholic fatty liver disease?
- (2016) Oliver John Kennedy et al. Therapeutic Advances in Gastroenterology
- Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials
- (2016) Shira Zelber-Sagi et al. Therapeutic Advances in Gastroenterology
- Tormentic acid inhibits LPS-induced inflammatory response in human gingival fibroblasts via inhibition of TLR4-mediated NF-κB and MAPK signalling pathway
- (2015) Cong-Xiang Jian et al. ARCHIVES OF ORAL BIOLOGY
- Natural Products on Nonalcoholic Fatty Liver Disease
- (2015) Jiao-Ya Xu et al. CURRENT DRUG TARGETS
- The Pros and the Cons for the Use of Silybin-Rich Oral Formulations in Treatment of Liver Damage (NAFLD in Particular)
- (2015) Natalia Rosso et al. CURRENT MEDICINAL CHEMISTRY
- Effect of Chicoric Acid on Mast Cell-Mediated Allergic Inflammation in Vitro and in Vivo
- (2015) Na Young Lee et al. JOURNAL OF NATURAL PRODUCTS
- Tormentic acid reduces inflammation in BV-2 microglia by activating the liver X receptor alpha
- (2015) A. Ma et al. NEUROSCIENCE
- Tormentic acid in foods exerts anti-proliferation efficacy through inducing apoptosis and cell cycle arrest
- (2015) Tian-Tian Zhang et al. Journal of Functional Foods
- Caffeine ameliorates high energy diet-induced hepatic steatosis: sirtuin 3 acts as a bridge in the lipid metabolism pathway
- (2015) Shi-Jie Zhang et al. Food & Function
- Evaluation of Hepatocyteprotective and Anti-hepatitis B Virus Properties of Cichoric Acid from Cichorium intybus Leaves in Cell Culture
- (2014) Hong-Li Zhang et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Verbascoside — A review of its occurrence, (bio)synthesis and pharmacological significance
- (2014) Kalina Alipieva et al. BIOTECHNOLOGY ADVANCES
- Silymarin ameliorates fructose induced insulin resistance syndrome by reducing de novo hepatic lipogenesis in the rat
- (2014) Prem Prakash et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Identification of chicoric acid as a hypoglycemic agent from Ocimum gratissimum leaf extract in a biomonitoring in vivo study
- (2014) Livia Marques Casanova et al. FITOTERAPIA
- Tormentic Acid, a Major Component of Suspension Cells of Eriobotrya japonica, Suppresses High-Fat Diet-Induced Diabetes and Hyperlipidemia by Glucose Transporter 4 and AMP-Activated Protein Kinase Phosphorylation
- (2014) Jin-Bin Wu et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Silymarin's Protective Effects and Possible Mechanisms on Alcoholic Fatty Liver for Rats
- (2013) Wei Zhang et al. Biomolecules & Therapeutics
- Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver
- (2013) Jiayin Yao et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Therapeutic approaches to non-alcoholic fatty liver disease: past achievements and future challenges
- (2013) Jia Xiao et al. Hepatobiliary & Pancreatic Diseases International
- Silibinin ameliorates steatosis and insulin resistance during non-alcoholic fatty liver disease development partly through targeting IRS-1/PI3K/Akt pathway
- (2013) Yongxiang Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Coffee and non-alcoholic fatty liver disease: Brewing evidence for hepatoprotection?
- (2013) Shaohua Chen et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The inhibition of oleic acid induced hepatic lipogenesis and the promotion of lipolysis by caffeic acid via up-regulation of AMP-activated kinase
- (2013) Chung-Chia Liao et al. JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
- Impact of coffee on liver diseases: a systematic review
- (2013) Sammy Saab et al. LIVER INTERNATIONAL
- Cell Suspension Culture of Eriobotrya japonica Regulates the Diabetic and Hyperlipidemic Signs of High-Fat-Fed Mice
- (2013) Chun-Ching Shih et al. MOLECULES
- Oral intake of chicoric acid reduces acute alcohol-induced hepatic steatosis in mice
- (2013) Marianne Landmann et al. NUTRITION
- Chicoric Acid Is an Antioxidant Molecule That Stimulates AMP Kinase Pathway in L6 Myotubes and Extends Lifespan in Caenorhabditis elegans
- (2013) Audrey Schlernitzauer et al. PLoS One
- α-Glucosidase inhibitory terpenoids from Potentilla fulgens and their quantitative estimation by validated HPLC method
- (2013) Deepak Kumar et al. Journal of Functional Foods
- Beneficial effects of silibinin against the progression of metabolic syndrome, increased oxidative stress, and liver steatosis in Psammomys obesus, a relevant animal model of human obesity and diabetes (在一种与人类肥胖以及糖尿病相关的动物模型肥沙鼠中,水飞蓟素具有拮抗代谢综合征进展、拮抗氧化应激增加以及拮
- (2013) Saida Bouderba et al. Journal of Diabetes
- Lycium barbarum polysaccharides protect rat liver from non-alcoholic steatohepatitis-induced injury
- (2013) J Xiao et al. Nutrition & Diabetes
- Chicoric acid: chemistry, distribution, and production
- (2013) Jungmin Lee et al. Frontiers in Chemistry
- Protection from non-alcoholic steatohepatitis and liver tumourigenesis in high fat-fed insulin receptor substrate-1-knockout mice despite insulin resistance
- (2012) A. Nakamura et al. DIABETOLOGIA
- Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial
- (2012) Carmela Loguercio et al. FREE RADICAL BIOLOGY AND MEDICINE
- Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: Analysis of isolated hepatic stellate cells
- (2012) MINA KIM et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Dietary Composition During Weight-Loss Maintenance
- (2012) Bruce Ryan Bistrian JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery
- (2012) Rodolphe Anty et al. JOURNAL OF HEPATOLOGY
- Coffee Extract Attenuates Changes in Cardiovascular and Hepatic Structure and Function without Decreasing Obesity in High-Carbohydrate, High-Fat Diet-Fed Male Rats
- (2012) Sunil K. Panchal et al. JOURNAL OF NUTRITION
- Milk Thistle and Its Derivative Compounds: A Review of Opportunities for Treatment of Liver Disease
- (2012) E.S. Hackett et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- Regular Exercise Is Associated with a Reduction in the Risk of NAFLD and Decreased Liver Enzymes in Individuals with NAFLD Independent of Obesity in Korean Adults
- (2012) Ji Cheol Bae et al. PLoS One
- Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis
- (2012) Federico Salamone et al. Translational Research
- Caffeine is protective in patients with non-alcoholic fatty liver disease
- (2011) A. Birerdinc et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis
- (2011) Federico Salamone et al. DIGESTIVE AND LIVER DISEASE
- Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis
- (2011) Jeffrey W. Molloy et al. HEPATOLOGY
- Effect of roasting on chlorogenic acids, caffeine and polycyclic aromatic hydrocarbons levels in two Coffea cultivars: Coffea arabica cv. Catuaí Amarelo IAC-62 and Coffea canephora cv. Apoatã IAC-2258
- (2011) Silvia A. V. Tfouni et al. INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY
- Silybin and the liver: From basic research to clinical practice
- (2011) Carmela Loguercio WORLD JOURNAL OF GASTROENTEROLOGY
- Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer
- (2010) Gagan Deep et al. CANCER AND METASTASIS REVIEWS
- Anti-apoptotic and anti-inflammatory effects of Silybum marianum in treatment of experimental steatohepatitis
- (2010) Safiyeh Aghazadeh et al. EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
- Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
- (2010) Herbert Tilg et al. HEPATOLOGY
- Milk thistle in liver diseases: past, present, future
- (2010) Ludovico Abenavoli et al. PHYTOTHERAPY RESEARCH
- Mechanisms of liver disease: cross-talk between the NF-κB and JNK pathways
- (2009) Salvatore Papa et al. BIOLOGICAL CHEMISTRY
- Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome
- (2009) C. H. KIM et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells
- (2009) Marco Trappoliere et al. JOURNAL OF HEPATOLOGY
- Solid State Mechanochemical Activation of Silybum marianum Dry Extract With Betacyclodextrins: Characterization and Bioavailability of the Coground Systems
- (2009) D. Voinovich et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells
- (2009) Sangmin Kim et al. PHYTOMEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started